NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LivsMed

LivsMed

Private
South KoreaHealthcare & Life Scienceshttps://livsmed.com

Last Round

IPO Announced

Dec 24, 2025

Est. Valuation

$1B

Total Funding Raised

$61.14M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

LivsMed is a medical devices company that develops articulating instruments designed for precision in minimally invasive surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

articulating surgical instrumentsmedical deviceslaparoscopic instrumentsminimally invasive surgerywristed instrumentshandheld roboticsrobotic surgery alternativemedtechsingle-use surgical instrumentstactile feedback surgeryvessel sealersurgical roboticssurgical staplerlaparoscopic camera

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LivsMed Comps

Public and private peers based on sector, stage, and business model.

LivsMed comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

LivsMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPO AnnouncedDec 24, 2025
Private EquityFeb 25, 2025
Series E ExtensionOct 19, 2023
Series DSep 13, 2020
Series AJul 1, 2016
Series A
Mar 1, 2015

LivsMed Investors

Notable investors and investment history

LivsMed investors
InvestorRounds
K2 Investment PartnersSeries D
Samsung Securities Co., Ltd.IPO
Mirae Asset SecuritiesIPO
NH Investment & SecuritiesPrivate Equity
Timefolio Asset ManagementPrivate Equity, Series E Extension, Series E
Wonik Investment PartnersSeries D
Stonebridge VenturesSeries D, Series E Extension, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 24, 2025

    $94M raised in IPO round.

  • Mar 12, 2025

    Introducing new 90° articulating vessel sealer at surgeon conference.

LivsMed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LivsMed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LivsMed's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range115
Year Founded2011
Last FundingDec 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.